Related Experiment Video

Updated: Jul 2, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Identification of a hepatitis C virus mutant lacking the hypervariable region 1 in a chronically infected patient

D Kmieciak1, P Migdalski, J Juszczyk

  • 1Department of Biochemistry and Molecular Biology, Karol Marcinkowski University of Medical Sciences, 6 Swiecickiego St., 60-781, Poznań, Poland. dkmiec@ump.edu.pl

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|August 30, 2008
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Related Experiment Videos

Last Updated: Jul 2, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Articles linked to this work by shared authors, journal, and citation graph.

Variations in the interferon and TLR3 genes may be associated with susceptibility to systemic lupus erythematosus and its clinical presentation.

Immunobiology·2024

Toll-like Receptor 4 Single-Nucleotide Polymorphisms and Heart Transplant Rejection.

Transplantation proceedings·2018

GREM2 nucleotide variants and the risk of tooth agenesis.

Oral diseases·2017

Common variants in DLG1 locus are associated with non-syndromic cleft lip with or without cleft palate.

Clinical genetics·2017

Cell-specific cytotoxic effect of pyrazole derivatives on breast cancer cell lines MCF7 and MDA-MB-231.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2017

Measuring thermal conductivity of thin films by Scanning Thermal Microscopy combined with thermal spreading resistance analysis.

Ultramicroscopy·2017

Serum Borrelia IgG as a rule-out test in suspected lyme neuroborreliosis: a large retrospective cohort study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Sex- and age-specific incidence and fraction of hospital contacts for infectious mononucleosis cases in Denmark in 1977-2011.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Standardization and evaluation of artificial intelligence-driven Fourier-transform infrared bio-typing for the discrimination of Escherichia coli and Shigella spp. on genus, species and serogroup level.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Risk factors for infection in NDM-colonized patients and applicability of the Giannella Risk Score.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

HBV/HCV coinfection and anti-tuberculosis drug-induced liver injury: from risk assessment and exploration of mechanisms to preventive considerations.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Double-antigen sandwich ELISA based on chimeric antigens for detection of antibodies to Trypanosoma cruzi in human sera - A phase II study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

Single-stage microscopic and endoscopic resection of spatially separate meningiomas through a single craniotomy.

Surgical neurology international·2026

Correction: Novel Behavior of the 2019 Novel Coronavirus With Invasion of the Cardiac Conduction System in the Young.

Cureus·2026

Integration of artificial intelligence into pharmacovigilance: A systematic review.

Research in social & administrative pharmacy : RSAP·2026

Recent advances in antioxidant nanozymes for the treatment of inflammatory bowel disease.

Nanomedicine : nanotechnology, biology, and medicine·2026

The expression window as a safety parameter for mRNA medicines.

Biochemical pharmacology·2026

Delivery architectures for oligonucleotide therapeutics in genetic and rare diseases: GalNAc-based hepatocyte targeting and extrahepatic translation.

Journal of controlled release : official journal of the Controlled Release Society·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us